Urology
NeoTract wins Medicare coverage for prostate treatment
FDA: Edap’s Ablatherm prostate cancer device ‘not approvable’
Prostate cancer: FDA panel recommends against approval for SonaCare’s Sonablate
SonaCare Medical said it will reposition its Sonablate prostate cancer device to treat a more aggressive stage of the disease after an FDA panel last week failed to recommend approval for the device.
SonaCare lands a date with the FDA for prostate cancer therapy
North Carolina-based SonaCare Medical is getting a day with the FDA, but the company’s prospects are murky given that it’s going before an advisory panel that just rejected a technology similar to SonaCare’s Sonablate 450 prostate cancer therapy.
UPDATE: FDA panel votes against Edap’s ultrasound prostate cancer ablation
Report: Surgical robots may be moot in cystectomy
The much-disputed field of robot-assisted surgery took another blow this week when doctors from Memorial Sloan Kettering Cancer Center warned that the high-tech procedure may be no better than traditional surgery for patients with invasive bladder cancer.